Mikael Trollsas, as Co-founder and Chief Executive Officer of Resurge Therapeutics Inc., is at the forefront of revolutionizing drug delivery systems, particularly in the field of urology. With over 25 years of experience in the drug delivery and medical device sectors, Mikael has cultivated a...
Mikael Trollsas, as Co-founder and Chief Executive Officer of Resurge Therapeutics Inc., is at the forefront of revolutionizing drug delivery systems, particularly in the field of urology. With over 25 years of experience in the drug delivery and medical device sectors, Mikael has cultivated a robust expertise in managing the entire lifecycle of innovative therapies, from initial concept through to regulatory approval and market launch. His leadership is pivotal in steering Resurge Therapeutics towards becoming a world-class developer of novel, minimally invasive drug delivery solutions that address significant unmet clinical needs.
Under Mikael's guidance, the company is currently advancing several key projects aimed at transforming patient care in urology. His strategic vision encompasses not only the technical aspects of product development but also the establishment of a strong organizational framework. He is dedicated to building a high-performing management team, fostering relationships with investors, and assembling a board of directors that includes some of the most respected clinical advisors and technical experts in the field. This collaborative approach ensures that Resurge Therapeutics remains at the cutting edge of innovation.
Mikael’s extensive skill set includes commercialization, cross-functional team leadership, and technology transfer, which are critical in navigating the complexities of R&D and GMP compliance. His commitment to quality systems and validation processes ensures that every product developed meets the highest standards of safety and efficacy. As a visionary leader, Mikael Trollsas is not only shaping the future of drug delivery in urology but is also setting new benchmarks for excellence in the life sciences industry.
